ArticleCancer gene therapy2004

Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model.

Takashi Saika et al.PubMed ↗Publisher ↗

No numbers read from the abstract.